Login to Your Account


DUBLIN – In one of the most baffling decisions the EMA has made in recent years, the agency's Committee for Human Medicinal Products last week issued a negative opinion in response to Takeda Pharmaceutical Co.'s application for approval of Ninlaro in relapsed or refractory multiple myeloma.


LONDON – As the days count down to the June 23 referendum on whether or not the U.K. should remain in the European Union (EU), the predicted impacts of either course are getting direr by the day.

DUBLIN – Bavarian Nordic A/S picked up a second bulk supply order for its Imvamune smallpox vaccine from the U.S. government, a $100 million deal that comes on top of the $133 million contract it secured last year.

More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: